Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Titan International (TWI) Research & Development (2016 - 2025)

Titan International (TWI) has disclosed Research & Development for 16 consecutive years, with $4.9 million as the latest value for Q4 2025.

  • Quarterly Research & Development rose 10.32% to $4.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.3 million through Dec 2025, up 11.04% year-over-year, with the annual reading at $18.3 million for FY2025, 11.04% up from the prior year.
  • Research & Development for Q4 2025 was $4.9 million at Titan International, up from $4.6 million in the prior quarter.
  • The five-year high for Research & Development was $4.9 million in Q4 2025, with the low at $2.2 million in Q2 2022.
  • Average Research & Development over 5 years is $3.4 million, with a median of $3.1 million recorded in 2023.
  • The sharpest move saw Research & Development fell 11.47% in 2022, then surged 43.79% in 2023.
  • Over 5 years, Research & Development stood at $2.6 million in 2021, then rose by 6.15% to $2.8 million in 2022, then increased by 10.28% to $3.1 million in 2023, then skyrocketed by 42.82% to $4.4 million in 2024, then rose by 10.32% to $4.9 million in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $4.9 million, $4.6 million, and $4.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.